Filter By Category
Archives
ANCROD
Generic Name: ANCROD
ABSTRACT -
Ancrod is a thrombin-like serine protease purified from the venom of the Malayan pit viper. It reduces circulating fibrinogen by cleaving fibrinopeptides and has been investigated as a defibrinogenating anticoagulant in vascular and stroke settings.
DOSAGE -
- Dosage should be determined only by a qualified healthcare professional.
- Ancrod is not marketed as a routine approved therapy in most regions.
- Historical clinical protocols used carefully monitored parenteral dosing.
- Fibrinogen levels, coagulation tests, and bleeding status must be monitored closely.
SIDE EFFECTS–
- Possible side effects include:
- Bleeding
- Hypofibrinogenemia
- Injection or infusion reactions
- Headache
- Nausea
- Thrombocytopenia
- Hypotension
- Allergic reactions
ALLRGIC REACTIONS–
- Possible allergic reaction symptoms include:
- Rash
- Urticaria
- Angioedema
- Bronchospasm
- Anaphylaxis-like reaction
- Important: Patients who develop an allergic reaction to Ancrod should seek immediate medical attention and inform all future healthcare providers of the allergy.
DRUG INTERACTIONS–
- Anticoagulants, antiplatelets, and thrombolytics can markedly increase bleeding risk.
- NSAIDs may increase bleeding risk.
- Hemostatic agents may counteract or complicate effects.
- Recent surgery or invasive procedures increase danger.
- Patients should inform healthcare providers about all prescription medicines, over-the-counter medicines, herbal products, vaccines, and supplements they are using.
PREAUTIONS–
- Use only where coagulation monitoring and emergency blood-product support are available.
- Avoid in active bleeding, major trauma, recent surgery, or high hemorrhage risk unless specifically justified.
- Monitor fibrinogen and neurologic status in stroke research.
- Screen for venom/protein allergy risk.
WARNINGS –
- Serious or fatal bleeding can occur.
- Not for unsupervised use.
- Do not combine with other anticoagulants unless protocol requires it.
- Keep out of reach of children.



. Developed by